(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)..., TORONTO,Nov.24/PRNewswire-FirstCall/-HamiltonT...eadingproviderofadvancedlasersystemsandinstruments...dayreportedoperationalandfinancialresultsforthethi...ts,-Revenuewas$1.46millioncomparedwith$1.43millio...with66.1percentinQ3,2008,-Netlossreducedto$148,000...
(Date:11/24/2009)...Program Connects Customers with Partners Validated... Genotek Products , Ottaw...a leading provider of products for biological samp...y announced its new global partner program. The pr...tek,s partner community and is designed to help pa...
(Date:11/23/2009)...es ultra-fast communication, computation and more ...t trying to use quantum states as carriers of info... physicists have shown, mathematically, how to gen...ion, while keeping the information intact. Their w...Review Letters and highlighted with a Viewpoint i...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3...TO, Sept. 18 /PRNewswire-FirstCall/ - ARIUS Resear...vering and developing the next wave of,antibody th...c.,shareholders and warrant holders approved the p...and Roche., At a special meeting held in Toronto ...ant holders approved the transaction, with 99.99% ...
...ales Agent and Distributor Gains Quick Traction in...nics,Corporation (BIEL) announced today that the n...Al-Mehyar Moh,d Basheer Halawy has taken for,appro...rn region., "We are pleased that the new agent ha...ting acceptance for our products. We look forward ...
...NG, Sept. 18 /Xinhua-PRNewswire/ -- Sinovac Biotec... in China, today announced that its,Annual General...8 was held,two weeks later, on September 18, 2008....eting, held at Sinovac,s,headquarters located at N...RC, resolutions for the Company,s 2007 Annual Repo...
Other Biology Technology:ARIUS sale approved by shareholders 2BioElectronics Corp. Announces $400,000 in New Orders From the Middle East 2(Date:11/23/2009)...TINew research presents strong evidence that the "... outdoor traffic-related pollution and indoor endo...e or the other exposure alone. , Environmental... (UC) College of Medicine have shown that children...rticles and indoor endotoxin during early life are...
(Date:11/23/2009)...O, November 23, 2009 - The time of day matters to ...new paper produced by a research team led by Profe...orough,s vice-principal for research and colleague... the St. George campus. , Capitalizing on thei... tree, the research team examined how poplar trees...
(Date:11/23/2009)...on, CT Current research suggests that a common or...he related report by Nichols et al, "Unique Lipids...ss of TLR2 Ligands Capable of Enhancing Autoimmuni...erican Journal of Pathology . , Multiple scleros... the brain and spinal cord, affects nearly 1 in 70...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 1Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 2Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 3Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 4Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 5Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 6Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 7Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4896 8Tamoxifen May Up Risk of Second More Aggressive Breast Cancer 55316 1Tamoxifen May Up Risk of Second More Aggressive Breast Cancer 55316 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 1SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 3SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 4... MADISON, WI, SEPTEMBER 2, 2008 Varying the rate o...ed makes intuitive sense, as farmers have long obs...f a single field. The availability of spatial yiel...nitors has provided a good resource for improved m...d potential of different areas within fields may i...
... GAINESVILLE, Fla. --- Large flightless birds of t...ian emus and cassowaries, South American rheas and...tless ancestor as once believed. , Instead, each ...ng from ancestors that did have the ability to fly...niversity of Florida zoology professor Edward Brau...
... Amidst the semi-arid stretches of Phoenix, a visi...utting across the horizon. Tempe Town Lake, on the...is just one of a multitude of lakes, small ponds, ...ivery, recreational opportunities and aesthetics, ...economics in the area. , What are the consequenc...
Other Biology News:A little nitrogen can go a long way 2A little nitrogen can go a long way 3New research challenges long-held assumptions of flightless bird evolution 2Evolving designer ecosystem sheds light on unintended consequences 2Evolving designer ecosystem sheds light on unintended consequences 3Evolving designer ecosystem sheds light on unintended consequences 4Rabbit Anti-hCG Polyclonal Antibody, Unconjugated from Abcam
Sheep Anti-Human Indolamine (Indoleamine) 2,3-dioxygenase Antibody, Unconjugated from CHEMICON
Glutathione Agarose Beads from BD Biosciences Pharmingen
Mouse NFkB Signaling Pathway, PCR Array for expression profiling from SuperArray Bioscience
Biology Products: